Extended Liver Health Panel

The Extended Liver Health Panel is a fasting blood test that measures six biochemical parameters connected with liver cells, bile flow, bilirubin processing, and blood protein levels. It includes AST, ALT, alkaline phosphatase (AP), GGT, total bilirubin, and total protein.

The panel provides a broader biochemical assessment than a basic liver panel. A basic panel commonly includes AST, ALT, and GGT, while the extended version adds AP, total bilirubin, and total protein. These additional measurements can help place changes in liver enzymes into a wider clinical context, but they cannot establish a diagnosis on their own.

What the Extended Liver Health Panel measures

• AST: An enzyme found in the liver, muscles, heart, and other tissues. An increased value may occur with liver cell injury, but it is not specific to the liver.
• ALT: An enzyme more closely associated with liver cells. Increased ALT may indicate liver cell irritation or injury, but the cause requires clinical assessment.
• GGT: An enzyme that may rise with liver or bile duct changes and can also be influenced by alcohol, medications, and other factors.
• Alkaline phosphatase (AP): A value that may help identify a biochemical pattern associated with bile flow or the biliary system. AP can also originate from bone, so it is interpreted together with GGT and other findings.
• Total bilirubin: Measures bilirubin produced during the normal breakdown of red blood cells and processed by the liver. Changes may have hepatic, biliary, hematologic, or benign causes.
• Total protein: Measures the combined amount of albumin and globulins in the blood. The result may be affected by hydration, nutrition, inflammation, protein production, or protein loss and is not specific to liver disease.

How the extended panel differs from the basic panel

AST, ALT, and GGT primarily provide information about patterns of enzyme activity. Adding AP helps assess whether an abnormal pattern may involve bile flow, while total bilirubin adds information about bilirubin processing and excretion. Total protein provides broader context regarding circulating proteins.

This makes the extended panel more informative than the basic panel when a wider initial biochemical assessment is needed. However, it is not a complete assessment of liver function. Depending on symptoms, medical history, and the results, further testing may include albumin, direct bilirubin, clotting tests, blood count, hepatitis testing, metabolic tests, ultrasound, elastography, or other imaging.

When the panel may be considered

The panel may be considered as part of a preventive laboratory assessment, follow-up of previously altered liver-related values, medication monitoring, evaluation of metabolic risk factors, or a broader investigation recommended by a doctor.

Some people seek testing because of fatigue and low energy. These symptoms are common and nonspecific and may be associated with sleep, stress, anemia, thyroid disorders, nutritional deficiencies, infection, metabolic conditions, medication effects, or many other causes. The presence of fatigue does not by itself indicate a liver problem.

How the testing process works

Preparation before testing

The blood sample is collected while fasting. Medication, supplement, alcohol, and previous laboratory information may be relevant to interpretation. Prescribed medication should not be stopped unless a doctor has provided specific instructions.

Blood sample collection

A venous blood sample is taken, and serum is used to measure all six parameters. The collection usually takes only a few minutes and does not require anesthesia or a recovery period.

Laboratory report

The report is available the same day. Each result is shown with the applicable reference range. A result outside the reference range is not automatically evidence of liver disease, and a result within the range does not exclude every liver or bile duct condition.

Understanding the results and limitations

The relationship between the values is often more informative than one isolated number. Predominantly elevated AST or ALT may suggest a different biochemical pattern from predominantly elevated AP and GGT. Bilirubin and total protein can add context, but interpretation also depends on age, symptoms, alcohol intake, medications, supplements, metabolic health, previous results, and other medical conditions.

The panel cannot show liver structure, fat accumulation, fibrosis, gallstones, bile duct obstruction, or focal liver changes. These questions may require ultrasound, elastography, CT, MRI, or another examination. Laboratory findings therefore need to be considered together with medical history, a physical examination, and imaging when clinically indicated.

Preparing an inquiry through ZagrebMed

For a more useful next-step assessment, include the reason for testing, current symptoms, medication and supplement use, relevant diagnoses, and previous laboratory or imaging reports. ZagrebMed can help organize the laboratory test and clarify which consultation or additional diagnostic step may be appropriate after the report is reviewed.